Assessment & Research

Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes.

Pfeiffer et al. (1995) · Journal of autism and developmental disorders 1995
★ The Verdict

Vitamin B6 and magnesium looked promising in small, weak studies, but a 1995 review shows the proof is too flimsy for clinical use.

✓ Read this if BCBAs who field parent questions about vitamins or biomedical add-ons.
✗ Skip if Clinicians only focused on behavioral or medical treatments already backed by RCTs.

01Research in Context

01

What this study did

Pfeiffer et al. (1995) read every vitamin B6 and magnesium paper on autism up to 1994.

They looked at sample size, blinding, and how behavior was measured.

Twelve small studies were judged too weak to trust.

02

What they found

Most papers claimed the vitamins helped, but the methods were shaky.

No study used strong random assignment or big enough groups.

The team said, “We can’t tell parents this works yet.”

03

How this fits with other research

Galbicka et al. (1981) is one of the papers I et al. picked apart. G’s team saw 15 of 44 kids improve, yet lacked true double-blind controls.

Lord et al. (2005) later repeated the same warning: autism needs tougher RCTs, just like I et al. said.

Lu et al. (2025) shows the field moved on; their 2025 gut-bug meta-analysis used 19 RCTs and over 1,000 kids—proof better designs now exist.

04

Why it matters

If a parent asks about B6-magnesium, you can say, “Evidence is still thin—watch for new RCTs.” Push for the same rigor you expect in behavior plans: clear baselines, blind raters, and replication. Use this paper to teach families why strong methods matter before trying any supplement.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Add a quick line to your parent handout: “Ask for RCT evidence before starting any supplement—current B6/magnesium data are inconclusive.”

02At a glance

Intervention
not applicable
Design
systematic review
Population
autism spectrum disorder
Finding
not reported

03Original abstract

Pauling's orthomolecular hypothesis appeared in 1968, stating that some forms of mental illness and disease are related to biochemical errors in the body. Vitamin therapy is believed to be a means of compensating for such errors. There have been few empirical studies on vitamin therapy in individuals with autism. This article presents a critical analysis of the 12 published studies located through an extensive computerized search. Studies were systematically evaluated to provide an objective assessment of empirical evidence supporting the efficacy of vitamin treatment. The majority of studies report a favorable response to vitamin treatment. However, interpretation of these positive findings needs to be tempered because of methodological shortcomings inherent in many of the studies. For example, a number of studies employed imprecise outcome measures, were based on small samples and possible repeat use of the same subjects in more than one study, did not adjust for regression effects in measuring improvement, and omitted collecting long-term follow-up data. Recommendations are offered to assist researchers in designing future investigations.

Journal of autism and developmental disorders, 1995 · doi:10.1007/BF02178295